Showing 7851-7860 of 10401 results for "".
- TARGET-DERM Real-World Study Expandshttps://practicaldermatology.com/news/target-derm-real-world-study-expands/2460550/Target RWE is expanding its active longitudinal dermatology registry, TARGET-DERM (
- Foreo Rolls Out Bear and Bear Mini with Help from TikTok Starshttps://practicaldermatology.com/news/foreo-rolls-out-bear-and-bear-mini-withhelp-from-tiktok-stars/2460537/
- FDA Accepts BLA for Bimekizumab for Plaque Psoriasishttps://practicaldermatology.com/news/fda-accepts-bla-for-bimekizumab-for-plaque-psoriasis/2460536/The FDA and the European Medicines Agency (EMA) have accepted the Biologics License Application (BLA) and Marketing Authorization Application (MAA), respectively, for bimekizumab for the treatment of adults with moderate to severe plaque psoriasis. “After a series of positive Phas
- Amytrx Therapeutics Comes Out of the Gate Strong with Lead Program AMTX-100, Clinical Development Planshttps://practicaldermatology.com/news/amytrx-therapeutics-comes-out-of-the-gate-strong-with-lead-program-amtx-100-clinical-development-plans/2460531/Amytrx Therapeutics, Inc. is on the move. Founded in 2014, Nashville-based Amytrx is developing novel therapies for inflammatory diseases with lead program AMTX-100 currently in clinical development for dermatologic indications. AMTX-100 is a new anti-inflammatory therape
- Actress Sarah Michelle Gellar Is CoolSculpting’s New International Ambassadorhttps://practicaldermatology.com/news/actress-sarah-michelle-gellar-is-coolsculptings-new-international-ambassador/2460518/
- Cutera’s Trusculpt Flex Hits Canadian Markethttps://practicaldermatology.com/news/cuteras-trusculpt-flex-hits-canadian-market/2460516/
- Cassiopea Scores FDA Approval for Winlevi (clascoterone cream 1%), First-in-Class Topical Acne Treatment Targeting the Androgen Receptorhttps://practicaldermatology.com/news/cassiopea-scores-fda-approval-for-winlevi-clascoterone-cream-1-first-in-class-topical-acne-treatment-targeting-the-androgen-receptor/2460513/The FDA has approved Winlevi (clascoterone cream 1%) for the treatment of acne in patients 12 years and older. "Th
- Dr. Marilyn Liang Assumes SPD Presidencyhttps://practicaldermatology.com/news/dr-marilyn-liang-assumes-sdp-presidency/2460468/Marilyn Liang, MD is the new president of the
- Noah Worcester Dermatological Society: No Meeting in 2020https://practicaldermatology.com/news/noah-worcester-dermatological-society-no-meeting-in-2020/2460453/
- Cynosure Reopening Survey: If You Wear Masks, They Will Come Backhttps://practicaldermatology.com/news/cynosure-reopening-survey-if-you-wear-masks-they-will-come-back/2460441/Fully 85 percent of people plan to return to aesthetic treatments within 12 months of COVID-19 restrictions being lifted, and 63 percent plan to return to practices within just three months of restrictions being lifted in their respective countries, according to a